Kristine Shields MSN, DrPH
Click the button below to view my past publications
Pending: Shields KE. Implementing New FDA Policy to Include Pregnant Women in Drug Trials to Achieve Evidence-based Pharmacotherapy. Poster presentation at the American Public Health Association Annual Meeting.
November 2-6, 2019
Pending: Shields KE. The Inclusion of Pregnant Women in Clinical Trials. Oral presentation at the Advancing Ethical Research Conference.
November 18-20, 2019
Shields KE. Pregnancy Registries' Contribution to Informed Clinical Practice. Invited oral presentation at the Third Annual International Conference for Individualized Pharmacotherapy in Pregnancy.
June 7, 2010
Shields KE, The HPV Vaccine - Examining the Safety Profile of Gardasil. Invited oral presentation at the Nurse Practitioners in Women’s Health Post-Graduate Seminar.
Atlantic City, NJ
Shields KE, New FDA Pregnancy Labeling - How it will inform your clinical practice. Invited oral presentation at the Nurse Practitioners in Women’s Health Post-Graduate Seminar.
Atlantic City, NJ
Shields KE, Informed consent processes in pregnancy registries. Invited oral presentation at the 48th Annual Meeting of the Teratology Society.
Abstract: Birth Defects Research (Part A), 82(5):336 (2008)
Shields KE. Sources of pregnancy exposure information – U.S. and worldwide. Invited oral presentation at the Teratology Society 45th Annual Meeting.
St. Pete’s Beach, FL
25-30 June 2005
Shields KE. Pregnancy registries as risk management tools. Invited oral presentation at PEA’s 4th Annual Risk Management Conference.
25-26 October 2005
Shields KE. A Pregnancy Registry Program in a Regulatory Environment. Invited oral presentation at the DIA symposium, Pregnancy Exposure Registries: Evaluating the Teratogenic Potential of Pharmaceutical Products Used at Clinical Doses.
May 24-25, 2004
Shields, KE. The Merck Pregnancy Registry Program. Invited oral presentation at Drug Information Association 11th Annual Symposium on Medical Communications.
Shields, KE. Pregnancy registries: Your role in drug safety assessment. Oral presentation at the Nurse Practitioners in Women’s Health Post-Graduate Seminar.
Shields, KE; Galea, S; Sweet, A; & Seward, J. Three-Year Results from the Pregnancy Registry for VARIVAX®. Poster presentation.
DIA Canada – Quebec
Shields KE, Galil K, Sharrar RG, Seward, J, Wiholm BE. Industry/CDC collaboration: The Pregnancy Registry for VARIVAX. Poster presentation at the First CDC Conference on Birth Defects and Developmental Disabilities: Charting the Course.
September 19, 2002
Shields KE, Bold T, Sharrar, RG. Pregnancy Registry for Singulair: Three-year analysis of data. Oral presentation at the World Asthma Meeting.
July 14, 2001